rilmenidine has been researched along with Apolipoprotein B-100, Familial Defective in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beucler, I; Dairou, F; Février, B; Scemama, M | 1 |
1 trial(s) available for rilmenidine and Apolipoprotein B-100, Familial Defective
| Article | Year |
|---|---|
Lipid profile and antihypertensive efficacy in hyperlipidemic hypertensive patients: comparison of rilmenidine and captopril.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Double-Blind Method; Female; Humans; Hyperlipoproteinemia Type II; Hypertension; Lipids; Male; Middle Aged; Oxazoles; Rilmenidine | 1995 |